Get started
Author

Ahmed Osman Shatila

Observed names: A Shatila, A. Shatila, Ahmed O. Shatila, Ahmed Shatila
Observed institutions: Spectrum Health, Gulf Medical University, Khalifa University of Science and Technology, Mafraq Hospital, Sheikh Shakhbout Medical City, Corewell Health Blodgett Hospital
ORCID: 0009-0003-6640-899X
Observed ORCID: 0009-0003-6640-899X
OpenAlex ID: A5089334508
An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion
2019 · Raed Alroughani, Jihad Said Inshasi, et al. · Neurology and Therapy · 28
PDF
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
2020 · Raed Alroughani, Jihad Inshasi, et al. · Neurology and Therapy · 27
PDF
Neurohospitalists Improve Door-to-Needle Times for Patients With Ischemic Stroke Receiving Intravenous tPA
2012 · Archit Bhatt, Ahmed Shatila · The Neurohospitalist · 21
Midwakh-induced seizures: Case series from UAE
2014 · Taoufik Alsaadi, Abdul Razzak Alkaddour, et al. · Epilepsy & Behavior · 12
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19
2021 · Jihad Inshasi, Raed Alroughani, et al. · Neurology and Therapy · 11
PDF
High-efficacy Therapies for relapsing-remitting Multiple Sclerosis: Implications for adherence. an Expert Opinion From the United Arab Emirates
2020 · Jihad Said Inshasi, Abubaker Almadani, et al. · Neurodegenerative Disease Management · 11
Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis according to disease activity
2020 · Raed Alroughani, Jihad Inshasi, et al. · Postgraduate Medicine · 10
PDF
Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines
2026 · Bassem Yamout, Riadh Gouider, et al. · CNS Drugs · 7
Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates
2024 · Anu Jacob, Ahmed Osman Shatila, et al. · Multiple Sclerosis and Related Disorders · 6
PDF
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study
2023 · Jihad Inshasi, Samar Farouk, et al. · Neurology and Therapy · 6
PDF
Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates
2021 · Jihad S. Inshasi, Sarmed Alfahad, et al. · Neurology and Therapy · 5
PDF
Consensus guidelines on the diagnosis and management of myasthenia gravis by the Saudi Arabia Neuromuscular and Electrodiagnostic Medicine and neuromuscular specialists from the Gulf Cooperation Council region
2025 · Ali Mohammed Alshehri, Mohammed H. Alanazy, et al. · Therapeutic Advances in Neurological Disorders · 4
Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice
2024 · Bassem Yamout, Raed Alroughani, et al. · Neurology and Therapy · 4
Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative review
2022 · Raed Alroughani, Jihad Inshasi, et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 4
The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
2020 · Raed Alroughani, Bart Van Wijmeersch, et al. · Therapeutic Advances in Neurological Disorders · 4
PDF
Post marketing real-world experience of ravulizumab in NMOSD
2025 · Anu Jacob, Azza Mahmoud, et al. · Multiple Sclerosis and Related Disorders · 3
PDF
A Case of Myasthenia Gravis Treated with Ocrelizumab
2023 · Kholoud Mohamed Aljaberi, Ahmed Naseer Mandalawi, et al. · Multiple Sclerosis and Related Disorders · 3
Hypovitaminosis D Status in Newly Diagnosed Cases of MS versus Control Group
2017 · Mehdi Saeedan, Yasamin Ghazvini Ko, et al. · Journal of Multiple Sclerosis · 3
Expert Guidance on Cognitive Impairment in Alzheimer's Disease: A Practical Seven-Step Approach from the United Arab Emirates
2025 · Tauofik Alsaadi, Abubaker Almadani, et al. · Neurology and Therapy · 2
PDF
Colitis Due to Anti-B Cell Therapy: A Clinical Reality
2023 · Kholoud Mohamed Aljaberi, Sudhir Palat Chirakkara Kumar, et al. · Multiple Sclerosis and Related Disorders · 2
Rebound of Multiple Sclerosis Disease Activity After Switching from Fingolimod or Natalizumab to Cladribine Tablets: Real World Experience from the Arabian Gulf
2023 · Jihad Inshasi, Raed Al Roughani, et al. · Multiple Sclerosis and Related Disorders · 2
Thyrotoxicosis With Development of Wernicke Encephalopathy in an Adolescent
2015 · Asma Deeb, Sadeq Qadry, et al. · AACE Clinical Case Reports · 2
Efficacy and safety of ocrelizumab in pediatric multiple sclerosis
2025 · Ahmad Altelly, Azza Mahmoud, et al. · Multiple Sclerosis and Related Disorders · 1
PDF
Cost-effectiveness of ofatumumab for the treatment of relapsing forms of multiple sclerosis in the United Arab Emirates
2025 · Jihad Inshasi, Yomna Nowier, et al. · Therapeutic Advances in Neurological Disorders · 1
Efficacy and Safety of Ocrelizumab in Pediatric Multiple Sclerosis
2023 · Ahmad Altelly, Victoria Mifsud, et al. · Multiple Sclerosis and Related Disorders · 1
Works count: 38
Citation count: 181
H-index: 7
I10-index: 7
Year
Topic
Type